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http://dx.doi.org/10During ontogeny, cells progress through multiple alternate differentiation states by activating
distinct gene regulatory networks. In this review, we highlight the important role of chromatin
priming in facilitating gene activation during lineage specification and in maintaining an epige-
netic memory of previous gene activation. We show that chromatin priming is part of a hugely
diverse repertoire of regulatory mechanisms that genes use to ensure that they are expressed at
the correct time, in the correct cell type, and at the correct level, but also that they react to
signals. We also emphasize how increasing our knowledge of these principles could inform
our understanding of developmental failure and disease. Copyright  2017 The Authors.
Published by Elsevier Inc. on behalf of ISEH - International Society for Experimental Hema-
tology. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).Concepts
Timing of gene activation during cell differentiation
involves the interaction of multiple cis-regulatory
elements
All development in metazoans starts with a single totipotent
cell that divides, activates differential sets of genes, and
produces many types of differentiated progeny with alter-
nate restricted lineage fates. Such cells eventually give
rise to distinct subsets of functionally specified cells that
comprise the organism. However, to replenish those cells
exiting the proliferative state and entering terminal differ-
entiation, stem cell systems have evolved that have ac-
quired the ability to either self-renew or differentiate. All
of these processes are under strict transcriptional control
and are driven by cell-type-specific, ubiquitous transcrip-
tion factors (TFs), which recruit epigenetic regulators that
modify the chromatin template to facilitate the assemblyo: Constanze Bonifer, University of Birmingham,
, UK; E-mail: c.bonifer@bham.ac.uk. And to
stitute of Cancer and Genomic Sciences, College
ntistry, University of Birmingham, Birmingham
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.1016/j.exphem.2017.01.003of the transcription machinery. Differential gene expression
takes place in topologically separate domains within indi-
vidual chromosomes (topology-associated domains or
TADs) that are dynamically reorganized in development
[1,2]. The developmental control of gene expression is
therefore a highly dynamic process that involves both the
cell-type-specific expression of TFs and the establishment
of specific chromatin landscapes presenting a defined target
for such factors. In the last few years, using single-gene and
system-wide studies, we have started to gain insights into
the molecular mechanisms that regulate these processes.
The vast majority of genes expressed in any one specific
cell type, which represent about half of all genes, are also
active in most cell types and are controlled by generic
mechanisms acting at gene promoters at the level of
mRNA expression. We commonly refer to these genes as
‘‘housekeeping’’ genes because they typically regulate
basic cellular functions such as metabolism and replication.
However, genes that are specific for certain cell types or
that encode crucial lineage determining regulators are un-
der strict developmental control. These genes tend to use
multiple cis-regulatory elements, ensuring that their expres-
sion is properly controlled at each developmental stage.
Much of what we know about developmental regulationf of ISEH - International Society for Experimental Hematology. This is an
s/by/4.0/).
2 C. Bonifer and P.N. Cockerill/ Experimental Hematology 2017;49:1–8comes from detailed studies of the temporal control of gene
expression of well-defined model genes during ontogeny,
many of them in the hematopoietic system. These include
the beta-globin gene cluster, which consists of several
genes that are expressed in a developmentally controlled
fashion, with the embryonic globin genes being expressed
first and the adult genes being expressed after birth, and
the homeobox (Hox) gene clusters, which encode regulators
of body patterning that are highly conserved across multiple
species and have an expression that is also under strict
developmental control. An extraordinary feature that these
gene clusters have in common is the fact that, in each
case, the order of activation of the individual genes during
ontogeny mirrors their order on the chromosome, and the
elements that define these patterns are contained within
these loci [3,4]. If the specific order of genes is disturbed,
then the temporal activation of the individual genes is
also altered [5,6], indicating that the linear organization
of genes is critical for their correct developmental control.
The erythroid-specifically expressed beta-globin locus is
regulated by a far upstream cis-regulatory region, the locus
control region (LCR) [7], which is rendered highly acces-
sible to both TFs and nucleases. Such elements are gener-
ally referred to as ‘‘DNase-hypersensitive sites (DHSs)
[8]. The LCR interacts physically in a developmentally
controlled fashion with downstream genes in the cluster
to drive the differential expression of embryonic and adult
globin genes [9,10]. Later experiments identified a relay of
stage-specifically expressed TFs that bind to both the LCR
and to downstream cis-regulatory elements that define the
timing of the stage-specific expression of each gene
[11,12]. These studies taught us that the cell-stage-
specific activation of a gene locus in development is a
stepwise and hierarchical process that involves multiple
cis-regulatory elements physically interacting with each
other. This principle also held up for tissue-specific genes
that are not organized in gene clusters or do not contain a
discrete LCR, such as the myeloid-specifically expressed
chicken lysozyme locus [13], the B-cell-specific Pax5 locus
[14], and the human alpha-globin locus [15–17]. These
genes are all regulated by complex sets of interacting regu-
latory elements that recruit multiple interacting TFs and
cofactors and are differently active during development or
drive expression in multiple tissues. At the level of chro-
matin organization, the interacting cis-regulatory elements
form active chromatin hubs or domains [9,18] involving
multiple DNA elements within active gene loci. Such clus-
ters of regulatory elements have recently been renamed
‘‘super enhancers’’ [19].
Poising promoters for rapid activation and repression:
The role of polycomb complexes
There are several ways of activating genes in a stepwise
fashion in development. Polycomb group proteins (PcGs)
play an important role in the developmental control ofgene expression and were originally identified as factors
that regulate lineage specification in Drosophila and main-
tain different patterns of gene expression within an organ-
ism. PcGs control an extensive regulatory network
functioning in many organisms, from insects to mammals,
to establish repressed or poised promoter states during
development. PcG-bound promoters typically bind the
non-elongating form of RNA-polymerase II and exist in a
bivalent state that contains the active histone H3 lysine 4
trimethylation (H3K4me3) mark together with the PcG-
associated repressive H3K27me3 mark [20]. By blocking
transcriptional elongation, PcG complexes can poise pro-
moters for the rapid reactivation of transcription at the
appropriate stage and time [21]. The removal of PcG com-
plexes from cells by gene targeting therefore leads to pre-
mature gene activation [22] and a global alteration of
gene expression patterns [23]. A number of system-wide
studies of PcG binding at different developmental stages
have shown that these complexes can display a highly dy-
namic binding pattern during development, with some pro-
moters being bound and repressed by PcG at one stage,
derepressed at the next stage to activate transcription tran-
siently, and then being rebound by PcG to enforce gene
silencing and block promiscuous transcription at the final
stage [24–26].
Gene loci show early signs of activation at distal
elements before the onset of gene expression
RNA synthesis from gene promoters is controlled at multi-
ple levels, from the initial opening up of promoter regions
to the recruitment of RNA-polymerase II and the process of
transcriptional elongation [27]. It is now well established
that developmentally regulated genes with complex regula-
tory regions comprising multiple DNA elements are acti-
vated in a stepwise fashion at the levels of chromatin
accessibility and transcriptional activation. The concept
that gene locus activation begins with chromatin priming
was shown first by single-gene analyses [28–33] and
confirmed later in multiple system-wide studies
[11,24,34–39]. Chromatin priming represents the underly-
ing basis for transcriptional priming in precursor cells
before alternate commitment decisions. This primed state
can be (but is not always) associated with low-level expres-
sion of multiple lineage-specific genes, the expression of
which later becomes restricted to one lineage after terminal
differentiation [40–42]. The maintenance of the primed and
the committed states is in each case controlled by specific,
tightly regulated TFs that become active at different stages
[24,43].
Chromatin priming is associated with different features,
all of which one way or another involve the action of TFs,
as summarized in Figure 1. One of the earliest studies of
chromatin priming was performed by the Zaret group
[28] using in vivo dimethyl sulfate (DMS) foot printing to
identify occupied TF-binding motifs at sequences harboring
Figure 1. Model of chromatin priming of developmentally regulated genes. These genes are organized in a compact chromatin structure in early precursor
cell types that give rise to multiple lineages. Once such cells have differentiated further down a given differentiation pathway and once specific TFs are
expressed in more mature progenitor cells (later progenitors), chromatin is then opened up, leading to a partially accessible chromatin structure and a limited
modification of histones with marks such as histone H3 lysine 4 monomethylation or dimethylation (me). In response to developmental cues or signals, cell-
fate-deciding and inducible TFs bind to both priming elements and enhancers, which then interact with the promoter to establish a fully active chromatin hub
in differentiated cells that is characterized by histones carrying acetylation (Ac) or lysine 4 trimethyl (me3) marks.
3C. Bonifer and P.N. Cockerill / Experimental Hematology 2017;49:1–8a liver-specific albumin enhancer in precursor gut endo-
derm, where this gene is transcriptionally silent. The asso-
ciated albumin gene is only activated after hepatic
specification when a number of additional factors bind to
nearby sites. An independent single-gene study examining
the PU.1 locus demonstrated that this gene is marked by
a selective demethylation of specific TF-binding sites at
an enhancer that is essential for the activation of the gene
(the upstream regulatory element [URE]). At the same
time, an increase in overall DNase I accessibility was
observed as a result of a hit-and-run mechanism involving
the TF RUNX1, followed by the assembly of a stable factor
complex and the activation of transcription [33] together
with the activation of additional transcriptional enhancers
[44]. TFs can also mediate locus derepression via
DNA-demethylation by direct interference with DNA
methyl transferases [45] or by recruiting demethylating
enzymatic activities such as TET enzymes [46]. The univer-
sality of priming mechanisms involving selective demethy-
lation, together with the early appearance of regions of
accessible chromatin, TF binding, and the presence of
monomethylated histone H3 lysine 4 before transcriptional
activation, was confirmed by genome-wide studies
[11,24,34,35,37–39,43].
Although priming of gene regulatory regions in precur-
sor cells is widespread, a recent study challenged the
concept that individual enhancers invariably have to be
primed at an early stage in order to be fully active later
in development [26]. That study defined priming on the ba-
sis of the presence of H3K4me1 and found that only a frac-
tion of enhancers in precursor cells remained active in
mature cells, indicating that the enhancer repertoire is re-
shaped dynamically during differentiation. However, acaveat of most genome-wide studies is that they do not
examine actual TF occupancy, which is a better predictor
of enhancer activity [47]. Goode et al. [24] did measure
TF binding during the differentiation of mouse embryonic
stem cells to macrophages and found a number of TF-
bound elements that were associated with low or absent
gene expression. Interestingly, this study noted that only a
very small number of distal elements preexist in a PcG-
associated repressed state, indicating that chromatin prim-
ing of enhancers does not typically involve PcG binding
[24]. However, specific developmentally regulated TFs
bound at active enhancers are likely to lead to the eviction
of polycomb complexes from PcG-bound poised promoter
regions, as exemplified in the alpha-globin locus [48].Mechanisms
Chromatin priming involves TF binding and is important
for the correct developmental regulation of genes
The question now arises, how important is chromatin prim-
ing for the developmental control of gene expression? Very
few studies have actually addressed the issue at a functional
level by following the developmental activation of genes in
a context in which priming is disturbed. The reason for this
is that such studies require the editing of endogenous genes
because the analysis of transgenes may be misleading due
to copy number, gene orientation, and genomic position ef-
fects (e.g., see Ellis et al. [49] or Calero-Nieto et al. [50]).
One study followed the differentiation of embryonic stem
cells into macrophages to examine the kinetics of develop-
mental upregulation of the Spi1 (Pu.1) gene in cells
harboring homozygous mutations within an ETS-binding
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(ETS) family factor FLI1 binds to the URE before the spec-
ification of hematopoietic cells, before the onset of Spi1
transcription in multipotent progenitor cells, and PU.1 sub-
sequently replaces FLI1 as part of an autoregulatory loop.
Interestingly, the mutation of the FLI1/PU.1-binding site
did not change the level of Spi1 transcription in macro-
phages. However, the time course of activation was remark-
ably different, with the mutated allele lagging behind in the
upregulation of gene expression compared with the wild-
type allele in normal cells. The molecular explanation for
this phenomenon is the presence of additional enhancers
in the Spi1 locus that are activated later in differentiation
by later-acting TFs (in this case, C/EBPa) that act indepen-
dently of PU.1 and push up gene expression to wild-type
levels [44]. A similar phenomenon was also seen at the
Pinx1 gene, which is regulated by a switch from the
early-acting TF GATA2 to the later-acting TF GATA1.
The deletion of a primed enhancer which binds GATA2 re-
sults in a delay in the activation of the gene during erythroid
differentiation up to a point when a second enhancer be-
comes active that binds GATA1 [12] A fascinating example
of how chromatin priming can be used to create function-
ally different cells is seen in the neuronal development of
Caenorhabditis elegans. Here, the priming of an early
enhancer by Notch signaling dictates the developmental
timing of regulation of the isy-6 miRNA locus: it is upregu-
lated earlier in those neuronal precursor cells that received
the signal compared with those that did not, thus leading to
a functional left–right asymmetry in otherwise morpholog-
ically symmetric neurons [52].
However, deregulation of timing of expression after the
deletion of a primed enhancer is not seen at all loci. The
deletion of the beta-globin LCR in its native context affects
expression levels, but not the timing of developmental
expression of the different globin genes regulated by TFs
binding to the individual genes [53]. These experiments
demonstrate that the order of the expression of TFs acti-
vating different enhancers dictates when and whether chro-
matin priming takes place. If this order is altered, cell
differentiation is disturbed, as shown by experiments that
switched the order of expression of two essential regulators
of hematopoietic development, C/EBPa and GATA2 [54].
Together with the findings of the Matthias group [26], these
experiments demonstrate that the activation of different en-
hancers and their cooperation over multiple differentiation
stages dictates the kinetics of upregulation of specific
genes.
Maintaining an epigenetic memory of previous
transcriptional activation
In addition to the finding that chromatin priming is impor-
tant for the correct temporal regulation of gene expression,
a number of recent studies have shown that it is vital for es-
tablishing a transcriptional memory of previous gene acti-vation [55]. Early studies by the Grange group [56] used
in vivo DMS foot printing to demonstrate that the induction
of the tyrosine aminotransferase (Tat) gene by glucocorti-
coids in the liver led to a demethylation of a binding site
for the liver-specific TF FOXA1 within 2 days that per-
sisted even after steroid removal. Once demethylation had
occurred, subsequent reactivation of the genes occurred
with much more rapid kinetics. A similar phenomenon
was seen in macrophages, a cell type that is highly respon-
sive to external stimuli such as proinflammatory cytokines
or bacterial lipopolysaccharide (LPS) [57]. Stimulation of
macrophages with LPS leads to activation of a number of
enhancers from the silent chromatin state (inducible en-
hancers), which is concordant with the binding of inducible
TFs. Importantly, once the stimulus is removed, factor bind-
ing on such enhancers is lost, but the formation of an active
enhancer complex leaves an active chromatin mark behind
that allows for a faster reactivation of associated genes after
restimulation.
The importance of maintaining a memory of previous
gene activation is paramount for cell types within the adap-
tive immune system. Both B and T cells retain a memory of
previous encounters with specific antigens by reverting
back to a quiescent state after the immune system has
cleared an infection, but then patrolling the body as mem-
ory cells to respond much more rapidly once the same an-
tigen is encountered again [58–61]. This feature of the
adaptive immune system is the basis for vaccination [62].
Prior to their first cycle of activation during an immune
response, naive T cells exist in a quiescent state with small
nuclei and barely any cytoplasm. It was found that the chro-
matin landscape at the IL3/CSF2 locus in naive T cells is
more similar to the inactive structure seen in the thymus
than it is to the active structure seen in recently activated
T cells [63–65]. The lack of chromatin modifications was
consistent with an inability to activate these genes in naive
T cells. However, once an appropriate immune response has
been triggered by antigen-presenting cells, dormant T cells
undergo a dramatic transformation by increasing their nu-
clear volume and activating a large battery of genes as
they enter a phase of rapid proliferation. The transformation
of naive T cells to T blast cells is driven by extensive chro-
matin remodeling [66,67], which leaves hundreds of im-
mune response genes in a primed state [64,68,69]. Once
these genes have been primed in activated T cells, they
remain primed when T cells revert to the quiescent state
as memory T cells [64,70]. Memory T cells have the ability
to reactivate genes faster and in response to weaker stimuli
than naive T cells [58,64,71–76].
The basis for the rapid recall response was until recently
far from clear because the transcriptional network in
resting-state memory T cells is not very different from
that seen in naive T cells [70]. However, a recent study
identified a simple mechanism that goes a long way toward
accounting for the underlying basis of the rapid recall
Figure 2. Model outlining the basis of immunological memory in T cells. In previously activated T cells, inducible genes can be maintained in a transcrip-
tionaly silent but primed state. Previous episodes of activation lead to the creation of primed DHSs that establish active chromatin domains encompassing
inducible enhancers. Any reencounter with antigen can lead to rapid recruitment of AP-1 to primed DHSs and induction of additional DHSs at inducible
enhancers by the T-cell receptor (TCR)-inducible factors nuclear factor of activated T cells (NFAT) and AP-1.
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cells [64]. This study performed extensive integrated ana-
lyses of accessible chromatin, together with chromatin
immunoprecipitation studies and genome editing, to inves-
tigate the molecular basis and significance of chromatin
priming in T cells [64]. We found that previously activated
T cells acquire and stably maintain w3000 primed DHSs
that are closely associated with inducible immune response
genes and the inducible enhancers that control them. As
summarized in Figure 2, these primed DHSs exist as
open chromatin regions occupied by constitutively ex-
pressed factors such as ETS-1 and RUNX1, which are
also expressed in naive T cells, but only gain the opportu-
nity to bind to these regions during the T blast cell transfor-
mation process, when inducible factors and remodelers first
open up these primed DHSs [64]. TFs such as activating
protein 1 (AP-1), the activity of which is signaling depen-
dent (inducible), are implicated in the initial opening up
of primed DHSs but, once established, RUNX1 and ETS-
1 appear to be largely sufficient to maintain primed DHSs
in both rapidly dividing T cells and quiescent circulating
memory T cells in the absence of additional stimuli [64].
The primed DHSs identified in recently activated T cells
do not typically function as transcriptional enhancers and
function instead to maintain domains of accessible
chromatin-carrying histone H3K4me2 and H3K27ac modi-
fications. There is evidently a requirement for the presence
of primed DHSs and active chromatin domains at inducible
loci because the inducible enhancers found in association
with primed DHSs can be induced in previously activatedT cells but not in naive T cells [64,65]. This concept was
confirmed by demonstrating that chromatin accessibility
at the IL3 locus was diminished following the targeted dele-
tion of a priming element located next to an inducible
enhancer, leading to a reduction in the speed of IL3 tran-
scriptional activation.
Taken together, these studies established the model pre-
sented in Figure 2 in which immunological memory is ac-
quired via a hit-and-run process involving transient
association of inducible factors that assist the recruitment
of constitutively expressed factors, which then function to
retain a transcriptional memory at inducible loci. Once es-
tablished, both the primed DHSs and the adjacent en-
hancers can recruit inducible factors much faster within
an active chromatin domain. The slow response in naive
T cells is mainly due to the inaccessibility of immune
response genes within condensed chromatin. Chromatin
priming maintained by primed DHSs adds an additional
dimension to previously defined mechanisms in memory
T cells, which include the replacement of repressive PcG
complexes by activating Trithorax group complexes at a
subset of immune response genes [77], increased mRNA
stability [78], and enhanced receptor signaling [72,79].
This priming model is reminiscent of the process termed
‘‘assisted loading’’ in which steroid receptors act in a tran-
sient manner to open up chromatin to enable the binding of
other factors [80]. A similar hit-and-run mechanism of tran-
scriptional memory was defined in plants, in which tran-
sient binding of a heat shock factor led to stable
maintenance of active chromatin modifications [81].
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cells is independent of repeated T-cell receptor signaling, it
does require intermittent episodes of cytokine signaling to
reinforce the pattern of reprogramming continually. In mice
and in humans, immunological memory decays in CD4þ
memoryT cells in the absence of the tumor necrosis factor su-
perfamily receptor OX40 [82,83]. This implies that intermit-
tent signaling from receptors to inducible factors such as
AP-1 is required for the stable long-term maintenance of
immunological memory, which in humans lasts for decades.
An open chromatin state has to be maintained actively
because, in the absence of activators, chromatin adopts an
inactive state (reviewed in Obier et al. [84]). The role of
PcG in maintaining gene expression patterns during cell di-
vision is well established (reviewed in Geisler and Paro
[85]), but, as outlined above, these proteins play little role
in the priming of distal elements. A question that is there-
fore intricately associated with chromatin priming is how
a primed state is maintained during cell division when the
chromatin landscape is disrupted by the replication machin-
ery and has to be reassembled [86]. A recent study has shed
light on this question by showing that highly accessible
chromatin regions are retained in mitotic chromatin [87].
Such regions colocalize with TF-binding sites, indicating
that factor binding may be retained. It has now been shown
for a number of TFs and cofactors that they are capable of
binding to mitotic chromatin and thus serve as ‘‘book-
marks’’ for the reassembly of factor complexes (reviewed
in Kadauke and Blobel [88]).Consequences
The studies described above have had a profound impact on
our mechanistic understanding of how we envisage the
genome to regulate developmental and immunological pro-
cesses because they highlight the fact that the interplay be-
tween TFs and a differential chromatin landscape is an
essential component of the temporal regulation of gene
activation in development. The idea that the chromatin
landscape has a profound influence on TF access and thus
on the dynamics of gene expression was suggested a long
time ago [89], but it is now clear from additional studies
[55] in yeast [90,91] and mammals [92], to quote a few ex-
amples, that control of chromatin accessibility is central for
the fine-tuning of gene activation. Another consequence of
chromatin priming as observed in T cells is the fact that
extracellular signals can influence the kinetics of gene acti-
vation profoundly via the maintenance of an open chro-
matin state. In addition, aberrant or aberrantly expressed
TFs, as found in hematological cancers, will derail the
finely tuned mechanisms that activate genes, thus leading
to a block in differentiation. Last, but not least, the vast ma-
jority of sequence variants between individuals and com-
mon disease variations affect cis-regulatory elements with
an immediate consequence for TF binding [93,94]. Life isrobust and has therefore built in redundancy into the system
by, for example by using enhancer duplications, thereby
buffering overly deleterious effects of such defects [95].
However, sequence variants will inevitably also affect prim-
ing elements and thus lead to a variable and individual
response to signals and alterations of the temporal regula-
tion of gene expression. To decipher the precise molecular
mechanisms of how such variations influence morphology
and physiology and cause disease will be a paramount
research task in the coming years.Acknowledgments
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